Bioscience Biotechnology Research Communications

An International  Peer Reviewed Refereed Open Access Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Heenu Dhar, and Poonam Salwan

Department of Pharmacology Shree Guru Gobind Singh
Tricentary University, Gurugram, Haryana, India

Corresponding author email: heenu_fmhs@sgtuniversity.org

Article Publishing History

Received: 19/05/2021

Accepted After Revision: 20/07/2021

ABSTRACT:

Since the outbreak of COVID-19 millions of people have been affected and thousands of people are dead. This infectious disease have propagated through a new virus strain as SARS CoV2 (Sever Acute Respiratory Syndrome Coronavirus 2). Natural compounds are always helping the humans to overcome many viral disease. Here, in this research an attempt was made to discover and help researchers to find the better phyto-chemical that can act as an inhibitor to treat the patients. Eugenol (Clove Oil) have been used to treat many viral and against many anti-cancer diseases. Molecular docking performed on Eugenol showed effective interaction with the Main Protease of SARS CoV2. Bonds and Distance between bonds also verified that Eugenol can be the candidate to develop an anti-viral vaccine or drug. Although further research is needed on this topic to overcome this pandemic.

KEYWORDS:

Atomic Contact Energy (ACE), COVID-19, Eugenol, Global Energy,
SARS CoV2, World Health Organisation (WHO).

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: